These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24771634)

  • 1. Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.
    Zhao Y; Cudkowicz ME; Shefner JM; Krivickas L; David WS; Vriesendorp F; Pestronk A; Caress JB; Katz J; Simpson E; Rosenfeld J; Pascuzzi R; Glass J; Rezania K; Harmatz JS; Schoenfeld D; Greenblatt DJ
    J Clin Pharmacol; 2014 Oct; 54(10):1180-7. PubMed ID: 24771634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.
    Berry JD; Shefner JM; Conwit R; Schoenfeld D; Keroack M; Felsenstein D; Krivickas L; David WS; Vriesendorp F; Pestronk A; Caress JB; Katz J; Simpson E; Rosenfeld J; Pascuzzi R; Glass J; Rezania K; Rothstein JD; Greenblatt DJ; Cudkowicz ME;
    PLoS One; 2013; 8(4):e61177. PubMed ID: 23613806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.
    Cudkowicz ME; Titus S; Kearney M; Yu H; Sherman A; Schoenfeld D; Hayden D; Shui A; Brooks B; Conwit R; Felsenstein D; Greenblatt DJ; Keroack M; Kissel JT; Miller R; Rosenfeld J; Rothstein JD; Simpson E; Tolkoff-Rubin N; Zinman L; Shefner JM;
    Lancet Neurol; 2014 Nov; 13(11):1083-1091. PubMed ID: 25297012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    Vet Res Commun; 2004 May; 28(4):331-8. PubMed ID: 15222737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of ceftriaxone in healthy horses.
    Ringger NC; Pearson EG; Gronwall R; Kohlepp SJ
    Equine Vet J; 1996 Nov; 28(6):476-9. PubMed ID: 9049497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.
    Simon N; Dussol B; Sampol E; Purgus R; Brunet P; Lacarelle B; Berland Y; Bruguerolle B; Urien S
    Clin Pharmacokinet; 2006; 45(5):493-501. PubMed ID: 16640454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total and unbound ceftriaxone pharmacokinetics in critically ill Australian Indigenous patients with severe sepsis.
    Tsai D; Stewart P; Goud R; Gourley S; Hewagama S; Krishnaswamy S; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2016 Dec; 48(6):748-752. PubMed ID: 27838278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and dosage regimen of ceftriaxone in E. coli lipopolysaccharide induced fever in buffalo calves.
    Dardi MS; Sharma SK; Srivastava AK
    J Vet Sci; 2005 Jun; 6(2):147-50. PubMed ID: 15933435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Failure of empirical treatment with ceftriaxone in motor neuron disease].
    Carod Artal FJ; Pérez López-Fraile I; Gracia Naya M; Girón Mombiela JA
    Neurologia; 1994 Jan; 9(1):29-31. PubMed ID: 8161465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pharmacokinetics and milk levels of ceftriaxone following single intravenous administration in healthy and endometritic cows.
    Kumar S; Srivastava AK; Dumka VK; Kumar N; Raina RK
    Vet Res Commun; 2010 Aug; 34(6):503-10. PubMed ID: 20571922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ceftriaxone in patients undergoing continuous renal replacement therapy.
    Goto K; Sato Y; Yasuda N; Hidaka S; Suzuki Y; Tanaka R; Kaneko T; Nonoshita K; Itoh H
    J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):625-631. PubMed ID: 27497425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?
    Ollivier J; Carrié C; d'Houdain N; Djabarouti S; Petit L; Xuereb F; Legeron R; Biais M; Breilh D
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis.
    Granero L; Santiago M; Cano J; Machado A; Peris JE
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2728-31. PubMed ID: 8593009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose Ceftriaxone for Bacterial Meningitis and Optimization of Administration Scheme Based on Nomogram.
    Grégoire M; Dailly E; Le Turnier P; Garot D; Guimard T; Bernard L; Tattevin P; Vandamme YM; Hoff J; Lemaitre F; Verdier MC; Deslandes G; Bellouard R; Sébille V; Chiffoleau A; Boutoille D; Navas D; Asseray N
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats.
    Albarellos GA; Kreil VE; Landoni MF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):345-52. PubMed ID: 17610408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does dexamethasone affect ceftriaxone [corrected] penetration into cerebrospinal fluid in adult bacterial meningitis.
    Buke AC; Cavusoglu C; Karasulu E; Karakartal G
    Int J Antimicrob Agents; 2003 May; 21(5):452-6. PubMed ID: 12727079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations.
    Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A
    J Clin Pharmacol; 2018 Dec; 58(12):1550-1556. PubMed ID: 29873816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of ceftriaxone in the first three month of life].
    Rondanelli R; Regazzi MB; Stronati M; Calvi M; Lombardi G; Rondini G
    Pediatr Med Chir; 1992; 14(1):55-9. PubMed ID: 1579518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the pharmacokinetics of Aspen Ceftriaxone and Rocephin in community-acquired meningitis.
    Richards GA; Elliott E; Shaddock EJ; Mushi D; Mzileni M; Ray R; Rulisa S; Seolwane F; Stacey SL; Stoltz A; Venturas JP; Schoeman H
    S Afr Med J; 2013 Sep; 103(12):906-9. PubMed ID: 24300626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.
    Nahata MC; Durrell DE; Barson WJ
    Chemotherapy; 1986; 32(2):89-94. PubMed ID: 3698727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.